Literature DB >> 25994407

Mismatch of presenting symptoms at first and recurrent acute myocardial infarction. From the MONICA/KORA Myocardial Infarction Registry.

Inge Kirchberger1, Margit Heier2, Hildegard Golüke3, Bernhard Kuch4, Wolfgang von Scheidt5, Annette Peters3, Christa Meisinger2.   

Abstract

BACKGROUND: It is unknown whether the symptoms of first and recurrent acute myocardial infarction (AMI) are similar in the same person. This study examined the frequency of symptom mismatch, which factors are associated with a symptom mismatch and how symptom mismatch is related to 28-day case fatality.
DESIGN: Observational study.
METHODS: The sample consisted of 1282 persons with a first and recurrent AMI, recruited from a population-based AMI registry, 1985-2011. Occurrence of 11 symptoms was recorded in first and recurrent AMI using standardized patient interview. Logistic regression modelling adjusted for demographic and clinical variables was applied.
RESULTS: Mismatch was highest for dyspnoea (40.6%) and lowest for chest symptoms (10.4%). Compared with women, men were less likely to have a mismatch of pain between the shoulder blades (odds ratio (OR) 0.58, 95% confidence interval (CI) 0.43-0.79), pain in the throat/jaw (OR 0.67, 95% CI 0.50-0.91), nausea (OR 0.62, 95% CI 0.47-0.82), vomiting (OR 0.50, 95% CI 0.36-0.71), or fear of death (OR 0.71, 95% CI 0.53-0.94), or to have three or more mismatching symptoms (OR 0.60, 95% CI 0.45-0.79). Persons with diabetes were more likely to have a mismatch in chest symptoms, whereas persons with hyperlipidaemia or persons who received any revascularization therapy at first infarction were significantly less likely to have a mismatch of chest symptoms. Twenty-eight-day case fatality significantly increased with the number of mismatching symptoms (OR 1.14, 95% CI 1.02-1.28).
CONCLUSIONS: Patients with AMI may benefit from information about the possibility that a recurrent infarction may be associated with different symptoms. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Myocardial infarction; re-infarction; survival; symptoms

Mesh:

Year:  2015        PMID: 25994407     DOI: 10.1177/2047487315588071

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

1.  Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry.

Authors:  Miriam Giovanna Colombo; Inge Kirchberger; Ute Amann; Margit Heier; Christian Thilo; Bernhard Kuch; Annette Peters; Christa Meisinger
Journal:  BMC Cardiovasc Disord       Date:  2017-07-24       Impact factor: 2.298

2.  Gender Differences in Factors Related to Prehospital Delay in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Hee Sook Kim; Kun Sei Lee; Sang Jun Eun; Si Wan Choi; Dae Hyeok Kim; Tae Ho Park; Kyeong Ho Yun; Dong Heon Yang; Seok Jae Hwang; Ki Soo Park; Rock Bum Kim
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

3.  Comparison of clinical profiles and care for patients with incident versus recurrent acute coronary syndromes in France: Data from the MONICA registries.

Authors:  Suzanne Machta; Victoria Gauthier; Jean Ferrières; Michèle Montaye; Samantha Huo Yung Kai; Stefy Gbokou; Katia Biasch; Marie Moitry; Philippe Amouyel; Jean Dallongeville; Aline Meirhaeghe
Journal:  PLoS One       Date:  2022-02-14       Impact factor: 3.240

4.  Clinical presentation in EMS patients with acute chest pain in relation to sex, age and medical history: prospective cohort study.

Authors:  Kristoffer Wibring; Markus Lingman; Johan Herlitz; Helena Pettersson; Anette Lerjebo; Angela Bång
Journal:  BMJ Open       Date:  2022-08-08       Impact factor: 3.006

5.  A systematic review of educational interventions aiming to reduce prehospital delay in patients with acute coronary syndrome.

Authors:  Sophia Hoschar; Loai Albarqouni; Karl-Heinz Ladwig
Journal:  Open Heart       Date:  2020-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.